Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ERII -24.3%, DNUT -19.6%, FLNC -14%, ASPN -10.4%, G -10.2%, ARM -9.5%, LNW -8.5%, ARGX -8.4%, FTNT -8.1%, SHOP -8.1%, ENOV -8%, FWRD -7.8%, EQX -7.6%, CLF -7.4%, SGI -7.2%, SPB -6.7%, TLN -6.7%, STAA -5.8% (also initiates cost controls and restructuring; also withdraws previous outlook), ASLE -5.5%, WRBY -4.7%, MBUU -4.7%, GPRE -4.5%, BBSI -4.3%, CNR -4.3%, SEMR -4.1%, MUSA -3.9%, NTR -3.8%, FNF -3.6%, TAP -3.6%, PTON -3.3%, INSM -3.3%, CENX -3.1%, ARHS -3.1%, CTVA -3%, USFD -2.9%, ADMA -2.7%, PLNT -2.7%, CCOI -2.7%, YETI -2.6%, PENN -2.4%, HASI -2.3%, SWKS -2.2% (also names new CFO), QNST -2.1%, ZG -2%, TNK -2% (also declares $1/sh special dividend), BLBD -2%, WBD -2%, ADTN -1.9%, TM -1.9%, SBGI -1.7%, SITC -1.7%, FUN -1.7%, COLD -1.7%, GT -1.6%
Other news:
- XGN -13.5% (stock offering)
- VRDN -0.8% (receives FDA Breakthrough Therapy Designation for Veligrotug)